The role of the novel lipokine palmitoleic acid in health and disease

Advances in Nutrition

Volumn 8, Issue 1, 2017, Pages 173S-181S

  Frigolet, María E ^a   Gutiérrez Aguilar, Ruth ^a,b  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cardiovascular disease; Diabetes; Diet; Fatty acids; Insulin resistance; Lipokine; Obesity; Palmitoleate

Indexed keywords

ADIPOCYTOKINE; MONOUNSATURATED FATTY ACID; PALMITOLEIC ACID;

ADIPOSE TISSUE; ANIMAL; DIABETES MELLITUS; DIET; DIETARY SUPPLEMENT; FAT INTAKE; FATTY LIVER; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLISM; OBESITY; PHARMACOLOGY;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS; DIET; DIETARY FATS; DIETARY SUPPLEMENTS; FATTY ACIDS, MONOUNSATURATED; FATTY LIVER; HUMANS; INSULIN RESISTANCE; METABOLIC DISEASES; OBESITY;

EID: 85011295571     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.115.011130     Document Type: Article

References (122)

1. Westphal SA. Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone 2008;9:23-9, discussion 30-1.
2. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007;92:399-404.
3. Kris-Etherton PM, Yu S, Etherton TD, Morgan R, Moriarty K, Shaffer D. Fatty acids and progression of coronary artery disease. Am J Clin Nutr 1997;65:1088-90.
4. Illingworth DR, Schmidt EB. The influence of dietary n-3 fatty acids on plasma lipids and lipoproteins. Ann N Y Acad Sci 1993;676:60-9.
5. Temme EH, Mensink RP, Hornstra G. Comparison of the effects of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. Am J Clin Nutr 1996;63:897-903.
6. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW, Cooney GJ. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 2000;279:E554-60.
7. Turinsky J, O'Sullivan DM, Bayly BP. 1, 2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 1990;265:16880-5.
8. Idris I, Gray S, Donnelly R. Protein kinase C activation: isozymespecific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001;44:659-73.
9. Ros E. Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 2003; 78(3, Suppl)617S-25S.
10. Kris-Etherton PM. AHA Science Advisory. Monounsaturated fatty acids and risk of cardiovascular disease. American Heart Association. Nutrition Committee. Circulation 1999;100:1253-8.
11. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998; 67(3, Suppl)577S-82S.
12. Gillingham LG, Harris-Janz S, Jones PJ. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 2011;46:209-28.
13. Siriwardhana N, Kalupahana NS, Moustaid-Moussa N. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Adv Food Nutr Res 2012;65:211-22.
14. Ruxton CH, Reed SC, Simpson MJ, Millington KJ. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 2004;17:449-59.
15. Goeransson G. The metabolism of fatty acids in the rat. V. Palmitoleic acid. Acta Physiol Scand 1965;63:428-33.
16. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008;134:933-44.
17. Guo X, Li H, Xu H, Halim V, Zhang W, Wang H, Ong KT, Woo SL, Walzem RL, Mashek DG, et al. Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice. PLoS One 2012;7: e39286.
18. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85-97.
19. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, Siscovick DS, Nettleton JA. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2013;97:854-61.
20. Mozaffarian D. Trans fatty acids-effects on systemic inflammation and endothelial function. Atheroscler Suppl 2006;7:29-32.
21. Yakoob MY, Shi P, Hu FB, Campos H, Rexrode KM, Orav EJ, Willett WC, Mozaffarian D. Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohorts. Am J Clin Nutr 2014;100:1437-47.
22. Ntambi JM, Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res 2004;43:91-104.
23. Lee WN, Lim S, Bassilian S, Bergner EA, Edmond J. Fatty acid cycling in human hepatoma cells and the effects of troglitazone. J Biol Chem 1998;273:20929-34.
24. Jaudszus A, Kramer R, Pfeuffer M, Roth A, Jahreis G, Kuhnt K. trans-Palmitoleic acid arises endogenously from dietary vaccenic acid. Am J Clin Nutr 2014;99:431-5.
25. Hagenfeldt L, Wahren J, Pernow B, Cronestrand R, Ekestrom S. Free fatty acid metabolism of leg muscles during exercise in patients with obliterative iliac and femoral artery disease before and after reconstructive surgery. J Clin Invest 1972;51:3061-71.
26. Motard-Bélanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, Couture P, Lamarche B. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 2008;87:593-9.
27. Wang Y, Jacome-Sosa MM, Ruth MR, Lu Y, Shen J, Reaney MJ, Scott SL, Dugan ME, Anderson HD, Field CJ, et al. The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-alpha and-gamma in a rodent model of dyslipidemia and the metabolic syndrome. Mol Nutr Food Res 2012;56:1234-46.
28. Bassett CM, Edel AL, Patenaude AF, McCullough RS, Blackwood DP, Chouinard PY, Paquin P, Lamarche B, Pierce GN. Dietary vaccenic acid has antiatherogenic effects in LDLr2/2 mice. J Nutr 2010; 140:18-24.
29. Chardigny JM, Destaillats F, Malpuech-Brugere C, Moulin J, Bauman DE, Lock AL, Barbano DM, Mensink RP, Bezelgues JB, Chaumont P, et al. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 2008;87:558-66.
30. Fatima T, Snyder CL, Schroeder WR, Cram D, Datla R, Wishart D, Weselake RJ, Krishna P. Fatty acid composition of developing sea buckthorn (Hippophae rhamnoides L.) berry and the transcriptome of the mature seed. PLoS One 2012;7:e34099.
31. Maguire LS, O'Sullivan SM, Galvin K, O'Connor TP, O'Brien NM. Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Int J Food Sci Nutr 2004;55:171-8.
32. Micha R, King IB, Lemaitre RN, Rimm EB, Sacks F, Song X, Siscovick DS, Mozaffarian D. Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr 2010;91:883-93.
33. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 2010;153:790-9.
34. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS. Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr 2010;92:1350-8.
35. Volk BM, Kunces LJ, Freidenreich DJ, Kupchak BR, Saenz C, Artistizabal JC, Fernandez ML, Bruno RS, Maresh CM, Kraemer WJ, et al. Effects of step-wise increases in dietary carbohydrate on circulating saturated datty acids and palmitoleic acid in adults with metabolic syndrome. PLoS One 2014;9:e113605.
36. Mangravite LM, Dawson K, Davis RR, Gregg JP, Krauss RM. Fatty acid desaturase regulation in adipose tissue by dietary composition is independent of weight loss and is correlated with the plasma triacylglycerol response. Am J Clin Nutr 2007;86:759-67.
37. Forsythe CE, Phinney SD, Feinman RD, Volk BM, Freidenreich D, Quann E, Ballard K, Puglisi MJ, Maresh CM, Kraemer WJ, et al. Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids 2010;45:947-62.
38. Chong MF, Hodson L, Bickerton AS, Roberts R, Neville M, Karpe F, Frayn KN, Fielding BA. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding. Am J Clin Nutr 2008;87:817-23.
39. Aarsland A, Wolfe RR. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. J Lipid Res 1998;39:1280-6.
40. Djoussé L, Weir NL, Hanson NQ, Tsai MY, Gaziano JM. Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure. Circ Heart Fail 2012;5:703-9.
41. Nall JL, Wu G, Kim KH, Choi CW, Smith SB. Dietary supplementation of L-arginine and conjugated linoleic acid reduces retroperitoneal fat mass and increases lean body mass in rats. J Nutr 2009; 139:1279-85.
42. Hiraoka-Yamamoto J, Ikeda K, Negishi H, Mori M, Hirose A, Sawada S, Onobayashi Y, Kitamori K, Kitano S, Tashiro M, et al. Serum lipid effects of a monounsaturated (palmitoleic) fatty acid-rich diet based on macadamia nuts in healthy, young Japanese women. Clin Exp Pharmacol Physiol 2004;31 Suppl 2:S37-8.
43. Garg ML, Blake RJ, Wills RB. Macadamia nut consumption lowers plasma total and LDL cholesterol levels in hypercholesterolemic men. J Nutr 2003;133:1060-3.
44. Zulyniak MA, Perreault M, Gerling C, Spriet LL, Mutch DM. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men. Metabolism 2013;62:1107-13.
45. Stenson WF, Seetharam B, Talkad V, Pickett W, Dudeja P, Brasitus TA. Effects of dietary fish oil supplementation on membrane fluidity and enzyme activity in rat small intestine. Biochem J 1989;263:41-5.
46. Abdolahi A, Georas SN, Brenna JT, Cai X, Thevenet-Morrison K, Phipps RP, Lawrence P, Mousa SA, Block RC. The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 2014;90:61-8.
47. Hirsch J, Farquhar JW, Ahrens EH, Jr., Peterson ML, StoffelW. Studies of adipose tissue in man. A microtechnic for sampling and analysis. Am J Clin Nutr 1960;8:499-511.
48. McLaren DS, Ajans ZA, Awdeh Z. Composition of human adipose tissue, with special reference to site and age differences. Am J Clin Nutr 1965;17:171-6.
49. Calder PC, Harvey DJ, Pond CM, Newsholme EA. Site-specific differences in the fatty acid composition of human adipose tissue. Lipids 1992;27:716-20.
50. Malcom GT, Bhattacharyya AK, Velez-Duran M, Guzman MA, Oalmann MC, Strong JP. Fatty acid composition of adipose tissue in humans: differences between subcutaneous sites. Am J Clin Nutr 1989;50:288-91.
51. Mamalakis G, Kafatos A, Manios Y, Kalogeropoulos N, Andrikopoulos N. Abdominal vs buttock adipose fat: relationships with children's serum lipid levels. Eur J Clin Nutr 2002;56:1081-6.
52. Phinney SD, Stern JS, Burke KE, Tang AB, Miller G, Holman RT. Human subcutaneous adipose tissue shows site-specific differences in fatty acid composition. Am J Clin Nutr 1994;60:725-9.
53. Pittet PG, Halliday D, Bateman PE. Site differences in the fatty acid composition of subcutaneous adipose tissue of obese women. Br J Nutr 1979;42:57-61.
54. Field CJ, Angel A, Clandinin MT. Relationship of diet to the fatty acid composition of human adipose tissue structural and stored lipids. Am J Clin Nutr 1985;42:1206-20.
55. Halliwell KJ, Fielding BA, Samra JS, Humphreys SM, Frayn KN. Release of individual fatty acids from human adipose tissue in vivo after an overnight fast. J Lipid Res 1996;37:1842-8.
56. Hodson L, Karpe F. Is there something special about palmitoleate? Curr Opin Clin Nutr Metab Care 2013;16:225-31.
57. Pinnick KE, Neville MJ, Fielding BA, Frayn KN, Karpe F, Hodson L. Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans. Diabetes 2012;61:1399-403.
58. Yli-Jama P, Haugen TS, Rebnord HM, Ringstad J, Pedersen JI. Selective mobilisation of fatty acids from human adipose tissue. Eur J Intern Med 2001;12:107-15.
59. Duckett SK, Volpi-Lagreca G, Alende M, Long NM. Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep. Diabetes Metab Syndr Obes 2014;7:553-63.
60. Andersson A, Nalsen C, Tengblad S, Vessby B. Fatty acid composition of skeletal muscle reflects dietary fat composition in humans. Am J Clin Nutr 2002;76:1222-9.
61. Tavares E, Gomez-Tubio A, Murillo ML, Carreras O. Brown and white adipose tissue lipid composition in three successive progenies of rats: effects of ethanol exposure. Arch Tierernahr 2001;55:53-67.
62. Douillet C, Bost M, Accominotti M, Borson-Chazot F, CiavattiM. Effect of selenium and vitamin E supplementation on lipid abnormalities in plasma, aorta, and adipose tissue of Zucker rats. Biol Trace Elem Res 1998;65:221-36.
63. Ivanovic N, Minic R, Djuricic I, Dimitrijevic L, Sobajic S, Zivkovic I, Djordjevic B. Brain and liver fatty acid composition changes upon consumption of Lactobacillus rhamnosus LA68. Int J Food Sci Nutr 2015;66:93-7.
64. Celik S, Akarcay H, Yilmaz O, Ozkaya A. Effects of intraperitoneally administered ubiquinone on the level of total lipid and fatty acids in rat liver. Cell Biochem Funct 2006;24:561-4.
65. Erbay E, Babaev VR, Mayers JR, Makowski L, Charles KN, Snitow ME, Fazio S, Wiest MM, Watkins SM, Linton MF, et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med 2009;15:1383-91.
66. Coleman SL, Park YK, Lee JY. Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages. Eur J Nutr 2011; 50:323-30.
67. Gong J, Campos H, McGarvey S, Wu Z, Goldberg R, Baylin A. Adipose tissue palmitoleic acid and obesity in humans: does it behave as a lipokine? Am J Clin Nutr 2011;93:186-91.
68. Foryst-Ludwig A, Kreissl MC, Benz V, Brix S, Smeir E, Ban Z, Januszewicz E, Salatzki J, Grune J, Schwanstecher AK, et al. adipose tissue lipolysis promotes exercise-induced cardiac hypertrophy involving the lipokine C16:1n7-palmitoleate. J Biol Chem 2015;290:23603-15.
69. Sarabi M, Vessby B, Millgard J, Lind L. Endothelium-dependent vasodilation is related to the fatty acid composition of serum lipids in healthy subjects. Atherosclerosis 2001;156:349-55.
70. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women. Br J Pharmacol 2002;136:1085-8.
71. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 2003;52:726-33.
72. Akazawa Y, Cazanave S, Mott JL, Elmi N, Bronk SF, Kohno S, Charlton MR, Gores GJ. Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J Hepatol 2010; 52:586-93.
73. Burns TA, Kadegowda AK, Duckett SK, Pratt SL, Jenkins TC. Palmitoleic (16:1 cis-9) and cis-vaccenic (18:1 cis-11) acid alter lipogenesis in bovine adipocyte cultures. Lipids 2012;47:1143-53.
74. Chan KL, Pillon NJ, Sivaloganathan DM, Costford SR, Liu Z, Theret M, Chazaud B, Klip A. Palmitoleate reverses high fat-induced proinflammatory macrophage polarization via AMP-activated protein kinase (AMPK). J Biol Chem 2015;290:16979-88.
75. Koeberle A, Shindou H, Harayama T, Shimizu T. Palmitoleate is a mitogen, formed upon stimulation with growth factors, and converted to palmitoleoyl-phosphatidylinositol. J Biol Chem 2012;287:27244-54.
76. Warensjö E, Ohrvall M, Vessby B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis 2006;16:128-36.
77. Okada T, Furuhashi N, Kuromori Y, Miyashita M, Iwata F, Harada K. Plasma palmitoleic acid content and obesity in children. Am J Clin Nutr 2005;82:747-50.
78. Paillard F, Catheline D, DuffFL, Bouriel M, Deugnier Y, Pouchard M, Daubert JC, Legrand P. Plasma palmitoleic acid, a product of stearoylcoA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis 2008;18:436-40.
79. Bernstein AM, Roizen MF, Martinez L. Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: a double-blinded, randomized, placebo controlled study. J Clin Lipidol 2014;8:612-7.
80. Stefan N, Kantartzis K, Celebi N, Staiger H, Machann J, Schick F, Cegan A, Elcnerova M, Schleicher E, Fritsche A, et al. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care 2010;33:405-7.
81. Vessby B, Tengblad S, Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 1994;37:1044-50.
82. Fabbrini E, Magkos F, Su X, Abumrad NA, Nejedly N, Coughlin CC, Okunade AL, Patterson BW, Klein S. Insulin sensitivity is not associated with palmitoleate availability in obese humans. J Lipid Res 2011; 52:808-12.
83. Kunesová M, Hlavaty P, Tvrzicka E, Stankova B, Kalouskova P, Viguerie N, Larsen TM, van Baak MA, Jebb SA, Martinez JA, et al. Fatty acid composition of adipose tissue triglycerides after weight loss and weight maintenance: the DIOGENES study. Physiol Res 2012;61:597-607.
84. Garaulet M, Hernandez-Morante JJ, Tebar FJ, Zamora S. Relation between degree of obesity and site-specific adipose tissue fatty acid composition in a Mediterranean population. Nutrition 2011;27: 170-6.
85. Vázquez-Vela ME, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 2008;39:715-28.
86. Markey O, McClean CM, Medlow P, Davison GW, Trinick TR, Duly E, Shafat A. Effect of cinnamon on gastric emptying, arterial stiffness, postprandial lipemia, glycemia, and appetite responses to high-fat breakfast. Cardiovasc Diabetol 2011;10:78.
87. Yang ZH, Takeo J, Katayama M. Oral administration of omega-7 palmitoleic acid induces satiety and the release of appetite-related hormones in male rats. Appetite 2013;65:1-7.
88. Cambien F, Warnet JM, Vernier V, Ducimetiere P, Jacqueson A, Flament C, Orssaud G, Richard JL, Claude JR. An epidemiologic appraisal of the associations between the fatty acids esterifying serum cholesterol and some cardiovascular risk factors in middle-aged men. Am J Epidemiol 1988;127:75-86.
89. Zong G, Ye X, Sun L, Li H, Yu Z, Hu FB, Sun Q, Lin X. Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese. Am J Clin Nutr 2012;96:970-6.
90. Djoussé L, Matthan NR, Lichtenstein AH, Gaziano JM. Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease. Am J Cardiol 2012;110:539-44.
91. Arab L. Biomarkers of fat and fatty acid intake. J Nutr 2003;133 Suppl 3:925S-32S.
92. Curb JD, Wergowske G, Dobbs JC, Abbott RD, Huang B. Serum lipid effects of a high-monounsaturated fat diet based on macadamia nuts. Arch Intern Med 2000;160:1154-8.
93. Nestel P, Clifton P, Noakes M. Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J Lipid Res 1994;35:656-62.
94. Shiba S, Tsunoda N, Wakutsu M, Muraki E, Sonoda M, Tam PS, Fujiwara Y, Ikemoto S, Kasono K. Regulation of lipid metabolism by palmitoleate and eicosapentaenoic acid (EPA) in mice fed a high-fat diet. Biosci Biotechnol Biochem 2011;75:2401-3.
95. Matthan NR, Dillard A, Lecker JL, Ip B, Lichtenstein AH. Effects of dietary palmitoleic acid on plasma lipoprotein profile and aortic cholesterol accumulation are similar to those of other unsaturated fatty acids in the F1B golden Syrian hamster. J Nutr 2009;139:215-21.
96. Yang ZH, Miyahara H, Hatanaka A. Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis 2011;10: 120.
97. Kuda O, Stankova B, Tvrzicka E, Hensler M, Jelenik T, Rossmeisl M, Flachs P, Kopecky J. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet. J Physiol Pharmacol 2009;60:135-40.
98. Fukuchi S, Hamaguchi K, Seike M, Himeno K, Sakata T, Yoshimatsu H. Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats. Exp Biol Med (Maywood) 2004;229:486-93.
99. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009;50: 1827-38.
100. Tomita K, Teratani T, Yokoyama H, Suzuki T, Irie R, Ebinuma H, Saito H, Hokari R, Miura S, Hibi T. Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis. Dig Dis Sci 2011;56:3045-52.
101. Lindgärde F, Vessby B, Ahren B. Serum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women. Am J Clin Nutr 2006;84:1009-13.
102. Salomaa V, Ahola I, Tuomilehto J, Aro A, Pietinen P, Korhonen HJ, Penttila I. Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism 1990;39:1285-91.
103. Gertow K, Rosell M, Sjogren P, Eriksson P, Vessby B, de Faire U, Hamsten A, Hellenius ML, Fisher RM. Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance. Eur J Clin Nutr 2006;60: 1406-13.
104. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-7.
105. Risérus U, Tan GD, Fielding BA, Neville MJ, Currie J, Savage DB, Chatterjee VK, Frayn KN, O'Rahilly S, Karpe F. Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. Diabetes 2005; 54:1379-84.
106. Iggman D, Arnlov J, Vessby B, Cederholm T, Sjogren P, Riserus U. Adipose tissue fatty acids and insulin sensitivity in elderly men. Diabetologia 2010;53:850-7.
107. Sauma L, Stenkula KG, Kjolhede P, Stralfors P, Soderstrom M, Nystrom FH. PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids. Nutrition 2006;22: 60-8.
108. Tsuchiya Y, Hatakeyama H, Emoto N, Wagatsuma F, Matsushita S, Kanzaki M. Palmitate-induced down-regulation of sortilin and impaired GLUT4 trafficking in C2C12 myotubes. J Biol Chem 2010; 285:34371-81.
109. Dimopoulos N, Watson M, Sakamoto K, Hundal HS. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J 2006;399:473-81.
110. Welters HJ, Diakogiannaki E, Mordue JM, Tadayyon M, Smith SA, Morgan NG. Differential protective effects of palmitoleic acid and cAMP on caspase activation and cell viability in pancreatic betacells exposed to palmitate. Apoptosis 2006;11:1231-8.
111. Diakogiannaki E, Dhayal S, Childs CE, Calder PC, Welters HJ, Morgan NG. Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic beta-cells. J Endocrinol 2007;194:283-91.
112. Pouchieu C, Chajes V, Laporte F, Kesse-Guyot E, Galan P, Hercberg S, Latino-Martel P, Touvier M. Prospective associations between plasma saturated, monounsaturated and polyunsaturated fatty acids and overall and breast cancer risk-modulation by antioxidants: a nested casecontrol study. PLoS One 2014;9:e90442.
113. Chajès V, Thiebaut AC, Rotival M, Gauthier E, Maillard V, Boutron-Ruault MC, Joulin V, Lenoir GM, Clavel-Chapelon F. Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol 2008;167:1312-20.
114. Shannon J, King IB, Moshofsky R, Lampe JW, Gao DL, Ray RM, Thomas DB. Erythrocyte fatty acids and breast cancer risk: a casecontrol study in Shanghai, China. Am J Clin Nutr 2007;85:1090-7.
115. Mamalakis G, Kafatos A, Kalogeropoulos N, Andrikopoulos N, Daskalopulos G, Kranidis A. Prostate cancer vs hyperplasia: relationships with prostatic and adipose tissue fatty acid composition. Prostaglandins Leukot Essent Fatty Acids 2002;66:467-77.
116. Simonsen NR, Fernandez-Crehuet Navajas J, Martin-Moreno JM, Strain JJ, Huttunen JK, Martin BC, Thamm M, Kardinaal AF, van't Veer P, Kok FJ, et al. Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Am J Clin Nutr 1998;68:134-41.
117. Chavarro JE, Kenfield SA, Stampfer MJ, Loda M, Campos H, Sesso HD, Ma J. Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancer. Am J Epidemiol 2013;178:1246-55.
118. Pandey M, Khatri AK, Dubey SS, Gautam A, Shukla VK. Erythrocyte membrane fatty acid profile in patients with primary carcinoma of the gallbladder. J Surg Oncol 1995;59:31-4.
119. Hattori T, Andoh T, Sakai N, Yamada H, Kameyama Y, Ohki K, Nozawa Y. Membrane phospholipid composition and membrane fluidity of human brain tumour: a spin label study. Neurol Res 1987;9:38-43.
120. Byberg L, Kilander L, Warensjo Lemming E, Michaelsson K, Vessby B. Cancer death is related to high palmitoleic acid in serum and to polymorphisms in the SCD-1 gene in healthy Swedish men. Am J Clin Nutr 2014;99:551-8.
121. Yee JK, Wahjudi PN, Vega J, Lim S, Martin A, Patterson ME, Cohen JN, Mao CS, Lee WN. Stearoyl-CoA desaturase enzyme 1 inhibition reduces glucose utilization for de novo fatty acid synthesis and cell proliferation in 3T3-L1 adipocytes. Metabolomics 2013;9:809-16.
122. Hess D, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One 2010;5:e11394.